DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. ENOV
4. AON
5. AZN
6. BLSM
7. GRMN
8. GPRO
9. KRMN
10. TXNM

Go back to DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations
(NASDAQ: DMAC) Delayed: 6.37 +0.02 (0.31%)
Previous Close $6.35    52 Week High $ 
Open $6.29    52 Week Low $ 
Day High $6.44    P/E N/A 
Day Low $6.27    EPS $ 
Volume 25,859